Compare QNC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QNC | SLP |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | Canada | United States |
| Employees | 13 | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.4M | 371.9M |
| IPO Year | 2026 | 1996 |
| Metric | QNC | SLP |
|---|---|---|
| Price | $2.02 | $18.42 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | ★ 925.7K | 148.8K |
| Earning Date | 04-28-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $59,577,000.00 |
| Revenue This Year | N/A | $3.80 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $42.81 |
| Revenue Growth | N/A | ★ 10.52 |
| 52 Week Low | $1.64 | $11.09 |
| 52 Week High | $3.59 | $21.01 |
| Indicator | QNC | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 42.72 | 57.51 |
| Support Level | $1.64 | $18.22 |
| Resistance Level | $2.09 | $18.46 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 31.87 | 33.33 |
Quantum eMotion Corp is a technology development company focused on developing and commercializing intellectual property in quantum-based cryptographic and cybersecurity solutions. The company delivers quantum-based security solutions in software and hardware that embed true quantum randomness at the chip level. Its software offerings include Sentry-Q for securing data across networks and applications; eFlux-Q, a cloud-based entropy distribution system for cryptographic systems and key generation; eCrypto-Q, a developer toolkit combining electron-based QRNG and post-quantum cryptography; and eHot-Q, a quantum-safe hot wallet SDK for digital asset protection. Its hardware solution includes eCore-Q, an electron-based QRNG providing high-speed entropy for cryptographic, AI, and IoT systems.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.